Obagi Nu-Derm System Normal-Dry Skin Transformation Trial

SPL

Last synced from FDA National Drug Code directory (United States) on June 3, 2026

Identification

ManufacturerObagi Cosmeceuticals LLC

CountryUS (United States)

ATC code—

Dispensing—

ReimbursedNo

SourceFDA National Drug Code directory (United States)

Last synced6/3/2026

Packs · 0

No packs registered.

Annotations

DailyMed SPL labels

1 version tracked

Raw payload (JSON)

{
  "route": null,
  "spl_meta": {
    "53023b16-8d64-4dfc-bc75-b4f248425c4d": {
      "match": "brand_token",
      "title": "OBAGI SKINTRINSIQ ANTIOXIDANT PROTOCOL (AVOBENZONE, HOMOSALATE, OCTISALATE. OCTOCRYLENE, AND OXYBENZONE) KIT [OBAGI COSMECEUTICALS LLC]",
      "spl_version": "4",
      "published_date": "2026-04-30"
    }
  },
  "productid": "62032-913_f1292c32-db82-4875-b681-b984c56f9cff",
  "productndc": "62032-913",
  "dosage_form": "KIT",
  "dea_schedule": null,
  "product_type": "HUMAN OTC DRUG",
  "substance_name": null,
  "proprietary_name": "Obagi Nu-Derm System Normal-Dry Skin Transformation Trial",
  "active_ingred_unit": null,
  "application_number": null,
  "marketing_category": "UNAPPROVED DRUG OTHER",
  "nonproprietary_name": "HYDROQUINONE, HOMOSALATE, OCTISALATE, ZINC OXIDE",
  "start_marketing_date": "20191202",
  "active_numerator_strength": null
}

Access this data programmatically

Query Obagi Nu-Derm System Normal-Dry Skin Transformation Trial and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.

Get a free API key Read the API docs